Literature DB >> 3076663

Ten Tanzanian transplants: problems and perspectives.

S L Basinda1, E E Maro, D G McLarty, A E Young, A J Wing.   

Abstract

A strategy of live related donor kidney transplantation coupled to the briefest possible preparatory period of haemodialysis was adopted as the most cost effective treatment for a selected group of 9 Tanzanian patients who received a total of 10 grafts. Patient and donor selection and preparation were carried out at Muhimbuli Medical Centre, Dar es Salaam, and the transplant procedure and first few months of follow-up were done at St. Thomas' Hospital, London. There was a high incidence of complications which drew attention to particular risk factors in the group treated. The high cost of treating these individuals emphasizes the need for research into chronic communicable and non-communicable diseases in Africa and highlights the dilemma of appropriate use of resources in serving the world's medical needs.

Entities:  

Mesh:

Year:  1988        PMID: 3076663      PMCID: PMC2429002          DOI: 10.1136/pgmj.64.756.778

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  2 in total

1.  Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation.

Authors:  P J Morris; J R Chapman; R D Allen; A Ting; J F Thompson; M S Dunnill; R F Wood
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

2.  The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

Authors:  T Sugimoto; S J Rosansky
Journal:  Am J Public Health       Date:  1984-01       Impact factor: 9.308

  2 in total
  2 in total

1.  Renal failure in Africa.

Authors:  Y K Seedat
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Developing nephrology services in low income countries: a case of Tanzania.

Authors:  Francis F Furia; Jacqueline Shoo; Paschal J Ruggajo; Kajiru Kilonzo; Gopal Basu; Karen Yeates; Santosh Varughese; Einar Svarstad; Onesmo Kisanga
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.